Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,324 INR | +2.43% | +8.40% | +41.48% |
Apr. 17 | The Tata Group Reportedly in Talks to Buy Stake in Fabindia?s Apparel Line | CI |
Apr. 17 | Tata, Reliance, DMart Reportedly in Talks to Acquire 24Seven from Godfrey Phillips | CI |
Sales 2024 * | 125B 1.5B | Sales 2025 * | 170B 2.04B | Capitalization | 1,500B 18B |
---|---|---|---|---|---|
Net income 2024 * | 9.78B 117M | Net income 2025 * | 13.54B 162M | EV / Sales 2024 * | 12 x |
Net cash position 2024 * | 2.75B 33.01M | Net cash position 2025 * | 8.1B 97.1M | EV / Sales 2025 * | 8.78 x |
P/E ratio 2024 * |
153
x | P/E ratio 2025 * |
109
x | Employees | 16,586 |
Yield 2024 * |
0.07% | Yield 2025 * |
0.07% | Free-Float | 56.61% |
1 day | +0.08% | ||
1 week | +3.20% | ||
Current month | +6.98% | ||
1 month | +8.81% | ||
3 months | +30.98% | ||
6 months | +112.16% | ||
Current year | +38.22% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 15-05-31 | |
Neeraj Basur
DFI | Director of Finance/CFO | - | 22-05-31 |
Krupa Anandpara
CMP | Compliance Officer | - | 23-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Noel Naval Tata
CHM | Chairman | 66 | 10-08-18 |
Director/Board Member | - | - | |
Director/Board Member | 61 | 14-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.53% | 6 M€ | +6.07% | - | |
0.07% | 441 M€ | +3.59% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 4,324 | +2.43% | 39 264 |
24-04-24 | 4,221 | +1.54% | 30,072 |
24-04-23 | 4,157 | -0.27% | 14,713 |
24-04-22 | 4,168 | +0.38% | 225,706 |
24-04-19 | 4,153 | +1.45% | 238,391 |
Delayed Quote Bombay S.E., April 25, 2024 at 02:10 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+38.22% | 18.01B | |
+11.30% | 7.29B | |
+10.69% | 6.99B | |
+13.41% | 6.67B | |
-3.33% | 5.81B | |
+43.38% | 5.69B | |
-6.91% | 5.15B | |
+19.86% | 4.63B | |
+8.81% | 3.69B | |
-12.58% | 3.27B |
- Stock Market
- Equities
- TRENT Stock